Citation: A. Laszlo et al., QUALITY ASSURANCE PROGRAM FOR DRUG SUSCEPTIBILITY TESTING OF MYCOBACTERIUM-TUBERCULOSIS IN THE WHO IUATLD SUPRANATIONAL LABORATORY NETWORK - FIRST ROUND OF PROFICIENCY TESTING/, The international journal of tuberculosis and lung disease, 1(3), 1997, pp. 231-238
Authors:
LUO C
CHINTU C
BHAT G
RAVIGLIONE M
DIWAN V
DUPONT HL
ZUMLA A
Citation: C. Luo et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN ZAMBIAN CHILDREN WITH TUBERCULOSIS - CHANGING SEROPREVALENCE AND EVALUATION OF A THIOACETAZONE-FREE REGIMEN, Tubercle and lung disease, 75(2), 1994, pp. 110-115
Authors:
MIGLIORI GB
BORGHESI A
SPANEVELLO A
ERIKI P
RAVIGLIONE M
MACIOCCO G
MORANDI A
BALLARDINI L
NERI M
Citation: Gb. Migliori et al., RISK OF INFECTION AND ESTIMATED INCIDENCE OF TUBERCULOSIS IN NORTHERNUGANDA, The European respiratory journal, 7(5), 1994, pp. 946-953
Authors:
CHINTU C
BHAT G
LUO C
RAVIGLIONE M
DIWAN V
DUPONT HL
ZUMLA A
Citation: C. Chintu et al., SEROPREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN ZAMBIAN CHILDREN WITH TUBERCULOSIS, The Pediatric infectious disease journal, 12(6), 1993, pp. 499-504
Authors:
CHINTU C
LUO CW
BHAT G
RAVIGLIONE M
DUPONT H
ZUMLA A
Citation: C. Chintu et al., CUTANEOUS HYPERSENSITIVITY REACTIONS DUE TO THIACETAZONE IN THE TREATMENT OF TUBERCULOSIS IN ZAMBIAN CHILDREN INFECTED WITH HIV-I, Archives of Disease in Childhood, 68(5), 1993, pp. 665-668